Retrospective Cohort Study for characterization of Sacubitril/Valsartan Drug Utilization by Strata of Pre-Index ACEi Dose using a Longitudinal Pharmacy Database From Germany
Latest Information Update: 16 Apr 2019
Price :
$35 *
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- 11 Apr 2019 Results assessing real-world treatment patterns of sacubitril/valsartan published in the European Journal of Heart Failure
- 15 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association